Pabst Labs is opening a new manufacturing facility and distribution center dedicated to cannabis beverages in Desert Hot Springs, California.
The "cutting edge” facility will allow the company to more than triple its production capabilities.
According to Chuck Barlick, Pabst Labs' director of production, the goal is to leverage over twenty years of beverage manufacturing experience while establishing a standard for quality and efficiency that would set the bar in all cannabis-infused beverages facilities.
On top of its eponymous Pabst Blue Ribbon 10mg High Seltzer, the company also produces Not Your Father's Cannabis-Infused Root Beer and the St. Ides Cannabis product line.
Other brands will be allowed to access the facility through co-packaging relationships to help raise beverage quality and opportunity across the industry.
THC-infused beverages are seeing a 40 percent growth rate, the fastest-growing category in the cannabis industry, according to the Cannabis Beverage Association (CBA).
PBR High Seltzer is one of the top-selling THC-infused carbonated beverages in California.


6 simple questions to tell if a ‘finfluencer’ is more flash than cash
Debate over H-1B visas shines spotlight on US tech worker shortages
Why financial hardship is more likely if you’re disabled or sick
US Dollar Slips Ahead of Key Inflation Data as Middle East Tensions Weigh on Markets
Wall Street Slides as U.S.-Iran Tensions Escalate; Tech Stocks Extend Losses in 2026
Time to buy local: war fuel price shocks reveal the folly of a long food supply chain
What’s the difference between baking powder and baking soda? It’s subtle, but significant
Airbus Aircraft Deliveries Surge in May 2026
US Dollar Dips as Middle East Tensions Ease; Markets Await Key US Inflation Data
Office design isn’t keeping up with post-COVID work styles - here’s what workers really want
Japan Producer Prices Surge in May, Strengthening Expectations of BOJ Rate Hike
Trump Administration Defends Anthropic AI Restrictions in Ongoing Federal Lawsuit
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Heritage, desire and diplomacy: why China still values scotch whisky
J.P. Morgan Sees Major Upside for Prysmian as Optical Fiber Prices Surge
GSK Reportedly Nears $9 Billion Acquisition of Cancer Drug Developer Nuvalent
Locked up then locked out: how NZ’s bank rules make life for ex-prisoners even harder 



